June 18, 2025
Headlines

What’s Going On With Monopar Therapeutics Shares Friday?

01 mins

Monopar entered into an agreement with Alexion, AstraZeneca Rare Disease for an exclusive worldwide license to ALXN-1840 for Wilson disease.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News